Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Events

10 Feb 2026 - 13 Feb 2026
17 Apr 2026 - 21 Apr 2026

Blood Sample Collection Cards Used for Screening Newborns

By LabMedica International staff writers
Posted on 07 May 2009
Dried blood spot cards are used to collect and transport blood specimens from newborns, which are later analyzed by public health laboratories. More...
Newborn screening is used to detect congenital disorders, many of which are treatable only when identified during the first days of life. A significant number of these are treatable when detected, but fatal when not.

PerkinElmer, Inc. (Waltham, MA, USA) has entered into a contract with ID Biological Systems (Greenville, South Carolina, USA) to become its exclusive, worldwide distributor for dried blood spot specimen collection cards used by newborn screening programs worldwide. The agreement is intended to deliver a consistent, high-quality supply of sample collection cards designed to customer specifications.

ID Biological Systems will produce the cards using Ahlstrom grade 226 filter paper. They are manufactured according to the Clinical and Laboratory Standards Institute (CLSI) standard for blood collection on filter paper for newborn screening programs. The paper has been successfully tested to the CLSI standard by the U.S. Centers for Disease Control and Prevention (CDC; Atlanta, GA, USA) Newborn Screening Quality program and other third party testing facilities.

"To secure the supply and delivery of U.S. Food and Drug Administration (FDA; Rockville, MD, USA)-approved high quality specimen cards is a priority for PerkinElmer and our newborn screening customers," said Ann-Christine Sundell, president, genetic screening, PerkinElmer. "This agreement expands our offering with a high quality product, and provides IDB Systems with a strong and proven distribution channel for its product."

Gary Resler, health services consultant for the Newborn Screening Program in the State of Washington has been using ID Biological Systems' specimen collection cards for samples processed in his laboratory for the past nine months. "A consistent supply of high quality sample cards is an imperative in a public health laboratory processing hundreds of neonatal samples each day," said Mr. Resler. "ID Biological Systems has delivered this quality and consistency along with a tremendous level of service."

Related Links:

PerkinElmer, Inc.
ID Biological Systems
U.S. Centers for Disease Control and Prevention
U.S. Food and Drug Administration



Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Autoimmune Liver Diseases Assay
Microblot-Array Liver Profile Kit
Automated Chemiluminescence Immunoassay Analyzer
MS-i3080
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.